Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from ...
Roughly 1.25 million Americans have Type 1 diabetes, so chances are you know somebody whose pancreas is taking the world’s longest lunch break. That person may be you. As it happens, there has never ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that it has entered into an agreement with the life ...
The new partnership between DexCom and Google to build out a new class of continuous glucose monitors spells out an interesting future for Type 2 diabetes care – and market dynamics in that space. To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback